LoLa Capital Partners

LoLa Capital Partners is a Boston-based venture capital and investment management firm focused on backing healthcare and biotechnology companies. Public filings and third-party profiles indicate the firm operates as an exempt reporting adviser and manages venture-style pooled investment funds, including LoLa Capital Partners I, LP and LoLa Capital Partners Growth I, LP. The firm appears to emphasize "new modality" investing, and Gregory Verdine has been identified publicly as its managing general partner. LoLa Capital Partners is not an operating drug-development company; rather, it functions as an investor in life science businesses, including participation in financings such as Stipple Bio's Series A round. As a result, it does not have an internal therapeutic pipeline in the same way a biotech or pharma company would.